Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
- Status
- RECRUITING
- Phase
- PHASE4
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Induction Chemo-Nivo in Unresectable Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
- Status
- RECRUITING
- Phase
- PHASE2
Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial
- Status
- SUSPENDED
- Phase
- PHASE2
A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Effect of Nivolumab vs Placebo in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010
- Status
- COMPLETED
- Phase
- PHASE1